Merck
Merck generated revenue of €5.26 billion in the second quarter of 2025. Life Science and Healthcare drove growth, while the acquisition of Springworks strengthened the oncology portfolio. Despite negative currency effects, the company raised its forecast for the full year. “We achieved solid organic sales and earnings growth,” emphasized Belén Garijo, Chair of the Executive Board and CEO of Merck.
The Hannover Messe is not about a single innovation. Isolated technological solutions will not solve the challenges of industry. Only ecosystems will moving away from individual value capture towards joint value creation. Nowhere is this more urgent than in the fight against climate change. According to the World Economic Forum, industrial value chains account for about 20 percent of total global...
Merck achieved a strong result in the 1st quarter of 2022. Sales rose 12.2 percent year-on-year to around EUR 5.2 billion. The main growth drivers were the Process Solutions business of Life Science, new healthcare products and the Semiconductor Solutions business of Electronics. Organic growth in Group sales totaled 7.8 percent. Operating profit increased by 12.5 percent to 1.17 billion euros...
